Avricore Health Inc. AVCR.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.64% | 78.23% | -145.64% | 17.00% | -515.58% |
| Total Depreciation and Amortization | -44.35% | 2,975.00% | -101.23% | 7.62% | 11.03% |
| Total Amortization of Deferred Charges | -- | -- | 3.70% | 3.85% | 13.04% |
| Total Other Non-Cash Items | -100.00% | -98.12% | 908.02% | -59.70% | 115.31% |
| Change in Net Operating Assets | -234.51% | 30.81% | 548.94% | 78.76% | -166.00% |
| Cash from Operations | -1,735.52% | 91.40% | 4.02% | 24.80% | -292.74% |
| Capital Expenditure | 95.00% | 33.33% | 73.68% | -776.92% | 97.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -25.00% | 31.03% | 73.15% |
| Cash from Investing | 95.00% | 63.64% | 58.96% | -219.05% | 92.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -140.00% | 66.67% | 50.00% | 128.57% | -450.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,620.10% | 90.87% | 7.20% | 21.63% | -413.06% |